# The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023, Regulation 13: Amendment of regulation 56 in relation to England, Scotland and Wales (fees payable in relation to clinical investigation notices)


(1) In regulation 56(1)—
(a) in sub-paragraph (a)(i), for “£2,920” substitute “£5,711”,
(b) in sub-paragraph (a)(ii), for “£3,570” substitute “£11,069”,
(c) in sub-paragraph (b)(i), for “£3,820” substitute “£7,472”, and
(d) in sub-paragraph (b)(ii), for “£5,040” substitute “£15,627”.
(2) After regulation 56(3A), insert—
“(3B) A person who requests a meeting with the Secretary of State in respect of an intended clinical investigation under regulation 16(1A) or 29(1A) must pay the following fees in advance of the meeting—
(a) £906 for a regulatory advice meeting under regulation 16(1A)(a) or 29(1A)(a); and
(b) £782 for a statistical review meeting under regulation 16(1A)(b) or 29(1A)(b).”.

---
Source: https://www.legislation.gov.uk/ukdsi/2023/9780348244502/regulation/13 (the official version)
Page: https://openlegislation.uk/draft-medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2023/regulation-13
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

